Artisan Partners Asset Management Inc. Reports July 2017 Assets Under Management
Aug 09, 2017 20:32 pm UTC| Business
MILWAUKEE, Aug. 09, 2017 -- Artisan Partners Asset Management Inc. (NYSE:APAM) today reported that its assets under management (AUM) as of July 31, 2017 totaled $111.9 billion. Separate accounts accounted for $56.1...
Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Aug 09, 2017 20:31 pm UTC| Business
SAN DIEGO, Aug. 09, 2017 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three months ended June...
Goldfield Announces Second-Quarter 2017 Results
Aug 09, 2017 20:31 pm UTC| Business
MELBOURNE, Fla., Aug. 09, 2017 -- The Goldfield Corporation (NYSE American:GV), a leading provider of electrical construction services for the utility industry and industrial customers through its subsidiaries, Power...
Aug 09, 2017 20:30 pm UTC| Business
CORAL GABLES, Fla., Aug. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating...
Xcel Brands Announces Second Quarter 2017 Financial Results
Aug 09, 2017 20:30 pm UTC| Business
Company Expanding its Presence in Dillard’sSecond Quarter Net Revenues of $8.4 MillionSecond Quarter GAAP Net Income of $0.2 MillionSecond Quarter Non-GAAP Net Income of $1.5 Million; Adjusted EBITDA of $2.3 Million NEW...
Aug 09, 2017 20:30 pm UTC| Business
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018Gencaro Development Program Has Been Granted Fast Track Designation by U.S. FDA WESTMINSTER, Colo., Aug. 09, 2017 -- ARCA biopharma, Inc....
XOMA to Present New Growth Strategy at the 2017 Wedbush PacGrow Healthcare Conference
Aug 09, 2017 20:30 pm UTC| Business
BERKELEY, Calif., Aug. 09, 2017 -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present the Company’s...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows